[ORGANIZATION]
University of Colorado Anschutz
Featured in 4 tracked stories · first seen
Situations
GLP-1 drugs: safety, clinical trends, and market impacts
195 clusters · 718 sources · last updated
Latest: GLP-1 medications drive R$ 27 billion market shift in Brazil
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. While research suggests secondary benefits—including a 21% lower risk of fragili
Also covered in
-
Antiviral treatment reduces ICU risk for children with influenza
[HEALTH] · 2 sources ·
-
Oral Semaglutide reduces heavy drinking in AUD trial
[HEALTH] · 12 sources ·